COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

The Effect of Platform-Matching Versus Platform-Switching Dental Implants on Peri-implant Hard and Soft Tissue Healing

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02536716
Recruitment Status : Unknown
Verified January 2018 by Henry Greenwell, University of Louisville.
Recruitment status was:  Active, not recruiting
First Posted : September 1, 2015
Last Update Posted : January 4, 2018
Information provided by (Responsible Party):
Henry Greenwell, University of Louisville

Brief Summary:
To compare platform-switched implants to platform-matched implants for replacement of a single missing tooth and their effect on: 1) Interproximal alveolar crest level in relation to implant platform. 2) Buccal implant recession. 3) Presence or absence of black triangle apical to the contact point. 4) Implant Success. 5) Adequate buccal tissue thickness.

Condition or disease Intervention/treatment Phase
Missing Tooth Procedure: Platform-matched dental implant Procedure: Platform-switched dental implant Not Applicable

Detailed Description:
Thirty patients will have a dental implant placed. Fifteen patients will be randomly selected by a coin toss to receive a platform-switched implant while the other fifteen will receive platform-matched implant. Each patient will receive a diagnostic work-up including standardized radiographs (periapicals), study casts, clinical photographs, and a clinical examination of teeth adjacent to the edentulous sites. Pre-surgical preparation will include detailed oral hygiene instructions. Baseline data will be collected at initial exam, and at 2, 4, 6, and 12 months. Parameters measured will include: plaque index, gingival index, probing depth, keratinized tissue, bleeding on probing, and digital radiographic examination. Pre-surgical measurements will include: cemento-enamel junction to osseous crest on adjacent teeth by direct measurement at surgery, and by radiograph at baseline, 2, 4, 6, and 12 months, periodontal form, periodontal biotype, tooth shape, and papilla harmony. Patients will be randomly selected for treatment group assignment using a coin toss before surgery by the mentor. One investigator who is unaware of group assignment will perform all baseline examinations and all follow-up examinations. Means and standard deviations will be calculated for all parameters. A paired t-test will be used to evaluate the statistical significance of the differences between initial and final data. An unpaired t-test will be used to evaluate statistical differences between the test and control groups. A sample size of 15 gives 80% statistical power to detect a difference of 0.5 mm of implant bone loss between groups. All surgical procedures will be completed by one operator under the direction of one mentor. Pre-surgical measurements will be taken first. Local anesthesia will be administered. The surgical procedure will consist of the reflection of full thickness flaps to expose the alveolar crest. The implant platform will be placed 3 to 4 mm apical to the mid-facial gingival margin using dental implant osteotomy drills for preparation of the site. The surgical procedures will be documented with clinical photographs. Sutures will be used to close the flap and bury the implant under the tissue. Records will be kept of healing periodically for the first 8 weeks, then at 4, 6 and 12 months. The test group will use a BioHorizons Tapered Internal Plus "platform-switched" implant. The control group will be BioHorizons standard Internal "platform-matched" implant. All patients will be seen at 1-2, 4, 6 and 8 weeks to monitor healing. At week 8 the implant will be uncovered surgically and provisionalized, and at the 4 month visit the final crown will be placed. Subsequent examinations will take place at 6 and 12 months. Post-surgically, patients will take an antibiotic (doxycycline hyclate 100 mg once a day for two weeks), an analgesic (Vicodin ES every 4-6 hours as needed for pain), and an anti-inflammatory agent (Naproxen 375mg every 12 hours for one week). At post-operative visits plaque removal, and oral hygiene instruction, as needed, will be performed along with clinical photographs and standardized radiographs as scheduled. The results of this study will allow comparison of peri-implant soft and hard tissue healing following placement of a BioHorizons "platform-switched" Tapered Internal Plus implant versus a standard Internal "platform-matched" implant in terms of the effect on marginal bone loss, buccal recession, and papilla fill.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 24 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effect of Platform-Matching Versus Platform-Switching Using Standard Internal Versus Tapered Internal Plus Dental Implants on Peri-implant Hard and Soft Tissue Healing
Actual Study Start Date : August 2015
Estimated Primary Completion Date : May 2018
Estimated Study Completion Date : May 2018

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: Platform-matched dental implant
Platform-matched dental implant placement to measure marginal bone loss, gingival margin position, and papilla fill.
Procedure: Platform-matched dental implant
A platform-matched dental implant will be placed surgically, restored with a crown and evaluated for up to 12 months.

Experimental: Platform-switched dental implant
Platform-switched dental implant placement to measure marginal bone loss, gingival margin position, and papilla fill.
Procedure: Platform-switched dental implant
A platform-switched dental implant will be placed surgically, restored with a crown and evaluated for up to 12 months.

Primary Outcome Measures :
  1. Marginal alveolar bone loss [ Time Frame: 12-months post dental implant placement ]
    Bone loss will be measured radiographically using a stent

Secondary Outcome Measures :
  1. Buccal implant recession [ Time Frame: 12-months post dental implant placement ]
    Buccal implant recession will be measured using a North Carolina probe using the adjacent teeth and incisal edge of the crown

  2. Papilla fill [ Time Frame: 12-months post dental implant placement ]
    Presence or absence of black triangle apical to the contact point

  3. Buccal soft tissue thickness around implant [ Time Frame: 12-months post dental implant placement ]
    Thickness will be measured with an endodontic file using a rubber stopper (objective measure of tissue thickness by penetrating tissue and measuring the thickness in mm).

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • 1. Have one edentulous site bordered by 2 teeth.
  • 2. Healthy persons at least 18 years old.
  • 3. Understands and has signed the informed consent.

Exclusion Criteria:

  • 1. Patients with uncontrolled diabetes, immune disease, or systemic disease that significantly affects the periodontium.
  • 2. Previous head and neck radiation.
  • 3. Patients who have been on IV bisphosphonates or oral bisphosphonates for > 3 years.
  • 4. Smokers.
  • 5. Patients who need prophylactic antibiotics prior to dental procedures.
  • 6. Patients with allergy to any medication or material used in the study.
  • 7. Chemotherapy in the previous 12 months.
  • 8. Severe psychological problems.
  • 9. Patients unable to sign the informed consent.
  • 10. Pregnant patients.
  • 11. History of allergy to common dentifrice ingredients.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02536716

Layout table for location information
United States, Kentucky
University of Louisville
Louisville, Kentucky, United States, 40202
Sponsors and Collaborators
University of Louisville
Layout table for investigator information
Principal Investigator: Henry Greenwell, DMD University of Louisville
Layout table for additonal information
Responsible Party: Henry Greenwell, Graduate Periodontics Program Director, University of Louisville Identifier: NCT02536716    
Other Study ID Numbers: 15.0448
First Posted: September 1, 2015    Key Record Dates
Last Update Posted: January 4, 2018
Last Verified: January 2018
Keywords provided by Henry Greenwell, University of Louisville:
Dental Implant
Additional relevant MeSH terms:
Layout table for MeSH terms
Tooth Loss
Periodontal Diseases
Mouth Diseases
Stomatognathic Diseases
Tooth Diseases
Tooth Abnormalities
Stomatognathic System Abnormalities
Congenital Abnormalities